ghk-cu acetat topical Cream GHK-Cu Topical vs Injection |

In the liver, BPC 157 reduced congestion and severe sinusoid enlargement

& Tchekhovskoi, D

By targeting healing where it actually happens, at the cellular level, BPC-157 promotes faster recovery and improved tissue function

"As we look to build an impactful portfolio of medicines to address patient needs, our data presented at ADA 2025 demonstrates not only how we are already delivering for a wide range of these needs with semaglutide, but that we are continuing to invest in innovation to support people living with serious chronic disease." The presentation of the CagriSema REDEFINE 1 and 2 trials are the first ever Phase 3 data presented on a GLP-1 and amylin receptor agonist combination, offering insights into the potential of this investigational medicine